LIVE POLLING
If you are a patient, caregiver, or family member
please go to http://PollEv.com/PPMD to participate live.
The 2018 PPMD Annual Conference marks the 24th time families, physicians, researchers, caregivers, industry partners, and those living with Duchenne have gathered to discuss all topics Duchenne.
This conference is like no other. Here, the key is community. All the pieces of this incredible community come together to learn, to listen, and to look forward at driving change. Every single voice is important, and every moment is rich. Now is the time for us to come together as a community and seize this moment.
The field is ripe with opportunity and at the PPMD Annual Conference partnerships are built, questions are asked and answered, and friendships are forged.
AGENDA
8:30 - Duchenne Research Overview: the landscape and the opportunities - Pat Furlong
9:00 - Conference Polling Begins - Ryan Fischer
Duchenne Citizen Science – contributing data to advance research
During this presentation we will discuss the value of contributing data.
We will also then pose live polling questions to the audience as well as the audience watching via live stream. This interactive polling will continue throughout the main session on Friday and Saturday.
9:20 - Intro to session – Restoring or Replacing Dystrophin - Moderator: Abby Bronson
9:20 - NS Pharma - Paula Clemens, MD - Hirofumi Komaki, MD
9:40 - WAVE Life Sciences - Wendy Erler, VP Patient Adv.
10:00 - Sarepta Therapeutics - Doug Ingram, CEO
10:20 - Summit, Plc - Michelle Avery, PhD
10:40 - PTC Therapeutics - Stuart Peltz, CEO
11:00 - Q&A
11:15 - Polling Time #1 and then a Break
11:30 - Panel Presentation: Studies currently underway in Gene Therapy
Moderator: Tim Cripe, MD, PhD
Panel: Jerry Mendell, MD , Nationwide Children’s
Jorge Quiroz, CMO, Solid BioSciences
Tara McDonnell Moorhead, Dir. Clinical Research, Pfizer
Kevin Flanigan, MD, Nationwide Children’s
If you are a patient, caregiver, or family member
please go to http://PollEv.com/PPMD to participate live.
The 2018 PPMD Annual Conference marks the 24th time families, physicians, researchers, caregivers, industry partners, and those living with Duchenne have gathered to discuss all topics Duchenne.
This conference is like no other. Here, the key is community. All the pieces of this incredible community come together to learn, to listen, and to look forward at driving change. Every single voice is important, and every moment is rich. Now is the time for us to come together as a community and seize this moment.
The field is ripe with opportunity and at the PPMD Annual Conference partnerships are built, questions are asked and answered, and friendships are forged.
AGENDA
8:30 - Duchenne Research Overview: the landscape and the opportunities - Pat Furlong
9:00 - Conference Polling Begins - Ryan Fischer
Duchenne Citizen Science – contributing data to advance research
During this presentation we will discuss the value of contributing data.
We will also then pose live polling questions to the audience as well as the audience watching via live stream. This interactive polling will continue throughout the main session on Friday and Saturday.
9:20 - Intro to session – Restoring or Replacing Dystrophin - Moderator: Abby Bronson
9:20 - NS Pharma - Paula Clemens, MD - Hirofumi Komaki, MD
9:40 - WAVE Life Sciences - Wendy Erler, VP Patient Adv.
10:00 - Sarepta Therapeutics - Doug Ingram, CEO
10:20 - Summit, Plc - Michelle Avery, PhD
10:40 - PTC Therapeutics - Stuart Peltz, CEO
11:00 - Q&A
11:15 - Polling Time #1 and then a Break
11:30 - Panel Presentation: Studies currently underway in Gene Therapy
Moderator: Tim Cripe, MD, PhD
Panel: Jerry Mendell, MD , Nationwide Children’s
Jorge Quiroz, CMO, Solid BioSciences
Tara McDonnell Moorhead, Dir. Clinical Research, Pfizer
Kevin Flanigan, MD, Nationwide Children’s
2018 PPMD Conference - Friday, June 29th - Morning Session therapist in tagalog | |
Likes | Dislikes |
2,940 views views | 3.09K followers |
Non-profits & Activism | Upload TimeStreamed live on 29 Jun 2018 |
Không có nhận xét nào:
Đăng nhận xét